14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARIA
Delisted

ARIAD Pharmaceuticals Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Mar 13, 2017

Range Low Price High Price Comment
30 days $23.87 $23.99 Monday, 13th Mar 2017 ARIA stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $11.69 $23.99
52 weeks $6.02 $23.99

Historical ARIAD Pharmaceuticals prices

Date Open High Low Close Volume
Dec 28, 2016 $12.67 $12.76 $12.52 $12.57 2 851 097
Dec 27, 2016 $12.29 $12.84 $12.23 $12.65 3 852 387
Dec 23, 2016 $11.81 $12.24 $11.81 $12.22 2 049 812
Dec 22, 2016 $11.85 $12.02 $11.69 $11.87 2 435 519
Dec 21, 2016 $12.17 $12.30 $11.87 $11.89 1 900 556
Dec 20, 2016 $12.16 $12.28 $12.07 $12.20 2 839 065
Dec 19, 2016 $12.46 $12.56 $12.07 $12.14 3 003 457
Dec 16, 2016 $12.48 $12.72 $12.41 $12.45 4 109 965
Dec 15, 2016 $12.60 $12.69 $12.40 $12.50 3 370 468
Dec 14, 2016 $12.40 $12.80 $12.35 $12.53 3 209 886
Dec 13, 2016 $12.39 $12.59 $12.19 $12.43 2 980 858
Dec 12, 2016 $12.49 $12.65 $12.24 $12.39 3 443 842
Dec 09, 2016 $13.05 $13.33 $12.67 $12.68 4 385 186
Dec 08, 2016 $12.90 $13.04 $12.43 $12.98 4 244 153
Dec 07, 2016 $13.25 $13.25 $12.32 $12.76 9 331 782
Dec 06, 2016 $13.27 $13.71 $13.15 $13.69 4 269 894
Dec 05, 2016 $13.34 $13.46 $13.10 $13.28 4 819 319
Dec 02, 2016 $13.10 $13.51 $12.93 $13.16 3 733 107
Dec 01, 2016 $13.50 $13.63 $12.94 $13.07 5 233 838
Nov 30, 2016 $13.86 $13.86 $13.36 $13.48 4 681 903
Nov 29, 2016 $14.26 $14.42 $13.72 $13.80 8 601 606
Nov 28, 2016 $13.99 $14.23 $13.63 $13.70 3 823 904
Nov 25, 2016 $13.89 $14.19 $13.61 $14.15 2 542 010
Nov 23, 2016 $13.11 $13.80 $12.86 $13.79 3 637 157
Nov 22, 2016 $13.70 $13.88 $13.21 $13.35 6 141 639
Click to get the best stock tips daily for free!

About ARIAD Pharmaceuticals

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, the European Union, Australia, Switzerland... ARIA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT